Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junwei Liu

Showing results (341-350 of 342) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 342 results.
Cell Research|September 18, 2024
Author Correction: Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humansLin Fan, Junwei Liu, Wei Hu, et al.
Nature Communications|May 12, 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.
Pageof 35

Showing results (341-350 of 342) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 342 results.
Cell Research|September 18, 2024
Author Correction: Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humansLin Fan, Junwei Liu, Wei Hu, et al.
Nature Communications|May 12, 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.
Pageof 35